B

Bio-Rad Laboratories IncClass A
D

BIO

326.96
USD
1.65
(0.51%)
Market Closed
Volume
9,817
EPS
9
Div Yield
-
P/E
-12
Market Cap
9,153,822,284
OverviewSignalsIdeasNews
Related Instruments
    AMGN
    AMGN
    2.27
    (0.87%)
    263.46 USD
    BIIB
    BIIB
    -0.780
    (-0.53%)
    146.590 USD
    B
    BMRN
    0.695
    (1.07%)
    65.680 USD
    GILD
    GILD
    1.460
    (1.60%)
    92.570 USD
    I
    ICUI
    3.600
    (2.35%)
    156.730 USD
    ILMN
    ILMN
    2.030
    (1.52%)
    135.930 USD
    I
    INCY
    1.910
    (2.85%)
    68.910 USD
    M
    MASI
    -0.420
    (-0.25%)
    169.550 USD
    REGN
    REGN
    -5.64
    (-0.80%)
    702.60 USD
    VRTX
    VRTX
    0.58
    (0.15%)
    397.15 USD
    More
News

Title: Bio/Rad Laboratories IncClass A

Sector: Healthcare
Industry: Medical Devices
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.